Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Oxford University and Novo Nordisk to collaborate at new diabetes research centre

International research company Novo Nordisk is investing £115 million in a new research centre at the University of Oxford, as part of a new type 2 diabetes research collaboration with the University.

International research company Novo Nordisk is investing £115 million in a new research centre at the University of Oxford, as part of a new type 2 diabetes research collaboration with the University. The partnership will enable scientists from Novo Nordisk and the University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes.  As part of this, Novo Nordisk is investing in a new research centre on the premises of the University of Oxford. The Novo Nordisk Research Centre Oxford will employ up to 100 Novo Nordisk researchers and the company’s total investment is expected to be

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy